CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Palo Alto Veterans Institute for Research

Academic/HospitalWebsite ↗

Also known as: Palo Alto Veterans Institute for Research | Ronald L. Dalman, MD

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Feb 29, 2024

Timeline

1980s

Jan 1, 1988
Palo Alto Veterans Institute for Research— Founded

Drugs by trial phase (10 distinct, 8 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

oxytocin

Other trials (1 own, 0 via acquisition)

rimabotulinumtoxinB

Indications

Studied for

Recent trials (11)

NCT05837845Lead sponsorPhase 2Feb 29, 2024
NCT05837845Sponsor investigatorPhase 2Feb 29, 2024
NCT03211013Lead sponsorEarly Phase 1Jul 10, 2017
NCT03211013Reponsible party - principal investigatorEarly Phase 1Jul 10, 2017
NCT03061136Lead sponsorPhase 4Oct 1, 2016
NCT02500784Lead sponsorPhase 2Jan 1, 2015
NCT01683084Lead sponsorPhase 4Sep 1, 2012
NCT01683084Sponsor investigatorPhase 4Sep 1, 2012
NCT00255086CollaboratorPhase 3May 1, 2005
NCT00183443Lead sponsorPhase 3Feb 1, 2005
NCT00282958Lead sponsorN/AFeb 1, 2003

Details

Founded: Palo Alto, CA, US Jan 1, 1988
Last known activity: Feb 29, 2024